Results 31 to 40 of about 21,308 (217)

Pre-diagnosis and pre-treatment loss to follow-up and associated factors among patients with presumed tuberculosis and those diagnosed in Uganda

BMC Health Services Research
Background Loss to follow-up (LTFU) of patients with presumed tuberculosis (TB) before completing the diagnostic process (pre-diagnosis LTFU) and before initiating treatment for those diagnosed (pre-treatment LTFU) is a challenge in the realization of ...
Rebecca Nuwematsiko, Noah Kiwanuka, Solomon T. Wafula, Mary Nakafeero, Lydia Nakanjako, Henry Luzze, Stavia Turyahabwe, Juliet N. Sekandi, Lynn Atuyambe, Esther Buregyeya   +9 more
doaj   +1 more source

Risk Factors Associated with Loss to Follow-Up during Tuberculosis Treatment in the Sanatorium Hospital of Luanda, Angola

Tropical Medicine and Infectious Disease
Background: Tuberculosis (TB) continues to be a serious public health threat that affects the most vulnerable populations. Patients who are lost to follow-up (LTFU) after TB diagnosis still represent one of the biggest challenges to TB control.
Domingos Vita, Maria Luisa Aznar, Joan Martínez-Campreciós, Debora Cristina Maindo Sebastiao Kansietoko, Israel Molina   +4 more
doaj   +1 more source

Factors associated with loss to follow-up before and after treatment initiation among patients with tuberculosis: A 5-year observation in China

Frontiers in Medicine, 2023
BackgroundLoss to follow-up (LTFU) is a significant barrier to the completion of anti-tuberculosis (TB) treatment and a major predictor of TB-associated deaths.
Youli Jiang, Jingfang Chen, Meng Ying, Linlin Liu, Min Li, Shuihua Lu, Zhihuan Li, Peize Zhang, Qingyao Xie, Xuhui Liu, Hongzhou Lu   +10 more
doaj   +1 more source

Loss to Follow-up in Cohort Studies [PDF]

Epidemiology, 2013
Although cohort members tend to be healthy and affluent compared with the whole population, some studies indicate this does not bias certain exposure-outcome associations. It is less clear whether this holds when socioeconomic position (SEP) is the exposure of interest.As an illustrative example, we use data from the Avon Longitudinal Study of Parents ...
Howe, L., Tilling, K., Galobardes, B., Lawlor, D.   +3 more
openaire   +3 more sources

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

Factors of Loss to Follow-up Antiretroviral Therapy in Islanded Area

Unnes Journal of Public Health, 2018
Loss to follow-up of antiretroviral therapy is when PLWHA (People Living with HIV/AIDS) do not come for antiretroviral therapy for more than 3 months. This study aimed to determine the factors of loss to follow-up antiretroviral therapy for PLWHA at Prof.
Thomas Laga Boro, Rafael Paun, Marthen R Pellokila   +2 more
doaj   +1 more source

Optimal Follow-Up Duration for Assessment of Birth Defects After In Vitro Fertilization–Embryo Transfer: A Multicenter 5-Year Cohort Study in China

Frontiers in Endocrinology, 2022
ObjectiveTo investigate the impact of a 5-year follow-up on the incidence of identified birth defects in children conceived using assisted reproductive technologies (ART).MethodsA 5-year cohort study was performed in three ART centers from January 2013 ...
Chun-Lin Liu, Ping Li, Gui-Feng Cai, Abraham Morse, Abraham Morse, Jun Liu, Zhi-Heng Chen, Xiu Zhang, Ling Sun   +8 more
doaj   +1 more source

Management of asthma in Benin: the challenge of loss to follow-up [PDF]

Public Health Action, 2013
SETTING: An asthma pilot project in Benin.OBJECTIVE: To assess the implementation of standard case management of asthma at three referral centres and three primary care centres.METHODS: The project began with local adaptation of international asthma guidelines, followed by situation analysis, pre-intervention, training and intervention.
G, Ade, M, Gninafon, L, Tawo, N, Aït-Khaled, D A, Enarson, C-Y, Chiang   +5 more
openaire   +2 more sources

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari, Regina Hadi Putri, Fatimah Assyifa, Judith Spijkerman, Gertjan Johannes Kaspers, Susi Susanah   +5 more
wiley   +1 more source